Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

115.64
Delayed Data
As of Oct 17
 -0.96 / -0.82%
Today’s Change
83.01
Today|||52-Week Range
153.15
+15.33%
Year-to-Date

Today’s Trading

Previous close116.60
Today’s open116.60
Day’s range115.29 - 117.25
Volume1,799,649
Average volume (3 months)1,490,885
Market cap$24.6B
Dividend yield--
Data as of 3:59pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-251.93%
Earnings growth (next 5 years)+92.90%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book52.49

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.10+0.15%
ALXNAlexion Pharmaceutic...+2.32+1.65%
BAXBaxter International...+0.27+0.42%
MYLMylan NV+0.36+0.94%
Data as of 4:01pm ET, 10/17/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts